|
Volumn 17, Issue 6, 2001, Pages 1083-1088
|
Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening
a a a a a a |
Author keywords
Asthma; Dosing time; Inhaled steroids; Once daily
|
Indexed keywords
ANTIHISTAMINIC AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CICLESONIDE;
CORTICOSTEROID;
HYDROCORTISONE;
NORFLURANE;
PLACEBO;
PRODRUG;
STEROID;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CONTROL;
DISEASE EXACERBATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG USE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
HYDROCORTISONE URINE LEVEL;
HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM;
MAJOR CLINICAL STUDY;
MALE;
PEAK EXPIRATORY FLOW;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SPIROMETRY;
SYMPTOM;
ADMINISTRATION, INHALATION;
ADOLESCENT;
ADULT;
AGED;
ASTHMA;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LUNG VOLUME MEASUREMENTS;
MALE;
MIDDLE AGED;
PREGNENEDIONES;
SPIROMETRY;
TREATMENT OUTCOME;
|
EID: 0034910074
PISSN: 09031936
EISSN: None
Source Type: Journal
DOI: 10.1183/09031936.01.00099701 Document Type: Article |
Times cited : (132)
|
References (25)
|